BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancer

Neoplasia

Volumn 7, Issue 12, 2005, Pages 1073-1080

  Li, Yunyan ^a   Dong, Xueyuan ^a   Yin, Yanhui ^a   Su, Yanrong ^a   Xu, Qingwen ^a   Zhang, Yuxia ^a   Pang, Xuewen ^a   Zhang, Yu ^a   Chen, Weifeng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Biomarker; BJ TSA 9; Lung cancer; Micrometastasis; Tumor specific gene

Indexed keywords

TUMOR MARKER; TUMOR MARKER BJ TSA 9; TUMOR MARKER LUNX; TUMOR MARKER SCC; UNCLASSIFIED DRUG; GLYCOPROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; PLUNC PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; METASTASIS; MONONUCLEAR CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; BLOOD; CANCER STAGING; CELL CULTURE; CHEMISTRY; CHROMOSOME 8; DNA SEQUENCE; FEMALE; GENETICS; LUNG TUMOR; MALE; METABOLISM; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; TUMOR EMBOLISM;

ANTIGENS, NEOPLASM; BLOTTING, NORTHERN; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SERPINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33644877818     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05406     Document Type: Article

References (33)

1. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol 2, 533-543.
2. Hosch SB, Scheunemann P, and Izbicki JR (2001). Minimal residual disease in non-small-cell lung cancer. Semin Surg Oncol 20, 278-281.
3. Matsunaga H, Hangai N, Aso Y, Okano K, Kawamura M, Kobayashi K, Kambara H, Hoger JH, and Mitsuhashi M (2002). Application of differential display to identify genes for lung cancer detection in peripheral blood. Int J Cancer 100, 592-599.
4. Castells A, Boix L, Bessa X, Gargallo L, and Pique JM (1998). Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 78, 1368-1372.
5. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, and Akiyoshi T (1996). Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68, 739-743.
6. Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS, and Chen WF (2002). Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86, 110-116.
7. Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, and Peck K (2005). Prognosis of non -small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 11, 173-179.
8. Burchill SA and Selby PJ (2000). Molecular detection of low-level disease in patients with cancer. J Pathol 190, 6-14.
9. Ghossein RA, Carusone L, and Bhattacharya S (1999). Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas. Diagn Mol Pathol 8, 165-175.
10. Alao JP, Mohammed MQ, Slade MJ, and Retsas S (1999). Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma. Melanoma Res 9, 395-399.
11. Kulik J, Nowecki ZI, Rutkowski P, Ruka W, Rochowska M, Skurzak H, and Siedlecki JA (2001). Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay. Melanoma Res 11, 65-73.
12. Smith B, Selby P, Southgate J, Pittman K, Bradley C, and Blair GE (1991). Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338, 1227-1229.
13. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, and Lustenberger P (1997). Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 74, 540-544.
14. Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernandez P, Krygier G, Simonet F, Barrios E, Muse I, et al. (2000). Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer 36, 717-723.
15. Johnson PW, Burchill SA, and Selby PJ (1995). The molecular detection of circulating tumour cells. Br J Cancer 72, 268-276.
16. Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, and Marks A (2000). RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat 60, 143-151.
17. Mattano LA Jr, Moss TJ, and Emerson SG (1992). Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase - polymerase chain reaction. Cancer Res 52, 4701-4705.
18. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, and Lo Gerfo PL (1996). Detection of circulating thyroid cells in peripheral blood. Surgery 120, 959-964 (discussion 964-955).
19. Paterlini-Brechot P, Vona G, and Brechot C (2000). Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions. Semin Cancer Biol 10, 241-249.
20. Wong IH, Lau WY, Leung T, and Johnson PJ (2000). Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 156, 141-149.
21. Castaldo G, Tomaiuolo R, Sanduzzi A, Bocchino ML, Ponticiello A, Barra E, Vitale D, Bariffi F, Sacchetti L, and Salvatore F (1997). Lung cancer metastatic cells detected in blood by reverse transcriptase - polymerase chain reaction and dot-blot analysis. J Clin Oncol 15, 3388-3393.
22. Peck K, Sher YP, Shih JY, Roffler SR, Wu CW, and Yang PC (1998). Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res 58, 2761-2765.
23. Salerno CT, Frizelle S, Niehans GA, Ho SB, Jakkula M, Kratzke RA, and Maddaus MA (1998). Detection of occult micrometastases in non - small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 113, 1526-1532.
24. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, and Hoon DS (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16, 2632-2640.
25. Dingemans AM, Brakenhoff RH, Postmus PE, and Giaccone G (1997). Detection of cytokeratin-19 transcripts by reverse transcriptase - polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 77, 213-220.
26. Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Riethmuller G, and Pantel K (1997). Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15, 2701-2708.
27. Kato H and Torigoe T (1977). Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40, 1621-1628.
28. Mino N, Iio A, and Hamamoto K (1988). Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 62, 730-734.
29. Kano M, Shimada Y, Kaganoi J, Sakurai T, Li Z, Sato F, Watanabe G, and Imamura M (2000). Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 82, 429-435.
30. Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M, Yokouchi H, Ozaki K, Monden M, and Tanigami A (2001). Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Int J Cancer 91, 433-437.
31. Mitas M, Hoover L, Silvestri G, Reed C, Green M, Turrisi AT, Sherman C, Mikhitarian K, Cole DJ, Block MI, et al. (2003). Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn 5, 237-242.
32. Shin JH, Chung J, Kim HO, Kim YH, Hur YM, Rhim JH, Chung HK, Park SC, Park JG, and Yang HK (2002). Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs. Aliment Pharmacol Ther 16 Suppl 2, 137-144.
33. Ko Y, Grunewald E, Totzke G, Klinz M, Fronhoffs S, Gouni-Berthold I, Sachinidis A, and Vetter H (2000). High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis of illegitimate gene expression. Oncology 59, 81-88.